May 15th, 2006 – In April the Capsulution
NanoScience AG, a Berlin based nanotechnology
company that is specialised in the development
of intelligent "packaging" systems
for active substances has become a member of
the European Nanotechnology Trade Alliance (ENTA).
As a leading organization and opinion leader
in nanotechnology, ENTA aims at mentoring, networking
and contacting among nanotech providers such
as Capsulution and with potential customers and
investors. Members of ENTA already include companies
such as Procter & Gamble, Unilever or Shell
Technology Ventures and many others.
Capsulution, it is very important to join forces
with other players in the field. We need to create
larger networking between different nanotech providers
on one hand, and with different customer industries
on the other hand." says Alexander Herrmann,
CFO at Capsulution. "In addition, we have to
clarify "What is nanotechnology about?" to
whom, who is not familiar with this new approach.
Finally, our membership with ENTA represents a quality
feature differentiating Capsulution from other suppliers."
with other leading nanotech companies, Capsulution's
contribution is dedicated to increasing the awareness
of consumers, industrial clients and investors
with respect to Nanotechnology and its social and
economic impact for the society. Del Stark, CEO
of ENTA: "We are very proud to have Capsulution
as a new member as this company is a leader in the
development of new life science products for the
The European Nanotechnology Trade Alliance (ENTA)
represents the interests of its members across
Europe ENTA offers an integrated programme aimed
at promoting the benefits of nanotechnology and
mitigating regulatory and reputational risk for
the whole industry and supporting all actions that
ensure new nanotechnologies are developed in a
safe and responsible manner.
In addition to the above, ENTA represents the interests
of nanotechnology businesses across Europe and acts
to bridge the gap between industry, governments,
science, and importantly, the public in promoting
the benefits of nanotechnology.
ENTA works closely with the media and government
bodies to express the nanotechnology industry's views
and needs, on for example, legislation, standards,
standard operating procedures, and public support.
Capsulution Nanoscience AG
Herr Dipl.-Kfm. Alexander Herrmann
Telefon: +49 (0)30-63 92 36 00
Fax: +49 (0)30-63 92 36 01
About Capsulution NanoScience AG:
Capsulution NanoScience AG is a leading nanotechnolopy
company focusing on the development of tailor-made
drug delivery systems and other innovative life
science products based on nano-sized capsules.
The company applies its worldwide-patented so-called
LBL-Technology®. Based on their minute size,
their functionality and their highly reproducible
production process the capsules can be used for
a multitude of different applications.
Accordingly, the precisely sized capsules can be
made to function in a manner to suit the intended
application, and can be given the appropriate biochemical,
electrical, optical and magnetic properties as
required by the customer. In order to meet customers
needs for complete product solutions Capsulution
has recently designated a Japanese licensee as
the preferred developer, manufacturer and distributor
for automated LBL-units. Only six month after the
signing of the licence agreement, EBARA has started
operation of the first prototype plant (LBL-Unit®)
for the manufacture of Capsulution's LBL capsules.
In 2005, renowned growth consultants Frost & Sullivan
have awarded the year's "Product Differentiation
Innovation Award" in the global nanobiotechnology
market to Capsulution NanoScience AG, Berlin. The
company has received the award for the innovative
and diverse use of their proprietary nanobiotechnology
product platform, which can be implemented in various
life sciences applications.